What’s New in Fertility?

0

In case you missed these, here are some exciting advances in the field of fertility:

New Hypothesis For Fertility Decline

A discovery made at the University of Montreal Hospital Research Center (CRCHUM) is offering a new hypothesis for why female fertility declines with age. The team at CRCHUM observed that in 50% of the eggs of older mice, microtubules did not properly assemble and segregate chromosomes during cell division. This resulted in aneuploid eggs, eggs with an incorrect number of chromosomes. Aneuploid eggs are known to become more common as women age and often result in miscarriage.

One More Use For Your Smartphone

Guys, soon your smartphone could tell you more about your fertility. A team at Brigham and Women’s Hospital developed a device that would allow men to analyze a semen sample using their phone– no trip to the fertility clinic. The app would report on sperm motility and concentration. The doctors hope a product like this could help remove the stigma associated with fertility testing and lead greater screening.

Treating PCOS in Adolescence Has Positive Effect on Fertility

A study conducted in Spain suggests early treatment for PCOS can significantly abate a later drop in fertility. The researchers recruited 36 teenage girls with PCOS to be treated with either an oral contraceptive or SPIOMET, a combination of drugs commonly prescribed to treat PCOS symptoms. The group of girls treated with SPIOMET was found to have higher ovulation rates and higher prevalence of normal ovulation.

Introducing, EVATAR

Scientists in Chicago have successfully simulated a woman’s 28-day menstrual cycle on a small device they are calling the EVATAR. The device is a system of units housing tissues from different parts of the female reproductive system including the vagina, uterus, and liver tissue.The EVATAR could be used to more accurately understand the effect of drugs and toxins on the female body. The project was inspired by the desire to investigate how drugs affect women differently than men as women are underrepresented in clinical trials. 

 

Thanks for reading!

Share.

About Author

Stephany Foster

Stephany Foster is the Associate Scientific Writer at Recombine, a genetic testing company based in New York City. She writes on topics spanning fertility, reproductive medicine, and recent advances in genomics. Stephany also writes about recently published research that Recombine presents at conferences and meetings around the globe. Before joining Recombine, Stephany interned at the George Church Lab at Harvard Medical School. She graduated from Brown University with an A.B. in Biology in 2014.